Cargando…
Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer
Musashi 2 (MSI2), a marker of stem and progenitor cells, has been identified as an oncogene. Various investigations have revealed that MSI2 is differently expressed in several types of blood cancer and solid cancers. However, its expression and biological functions in gastric cancer (GC) remain uncl...
Autores principales: | Yang, Ziguo, Li, Jie, Shi, Yulong, Li, Leping, Guo, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365935/ https://www.ncbi.nlm.nih.gov/pubmed/30854035 http://dx.doi.org/10.3892/ol.2019.9889 |
Ejemplares similares
-
Overexpression of Musashi-1 protein is associated with progression and poor prognosis of gastric cancer
por: Shou, Zhangxuan, et al.
Publicado: (2017) -
Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis
por: Liu, Qiuhua, et al.
Publicado: (2019) -
Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer
por: Zong, Zhen, et al.
Publicado: (2016) -
Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival
por: Wang, Xiao-Yang, et al.
Publicado: (2010) -
Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)